Literature DB >> 29991135

EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer's Disease.

Christian Sandøe Musaeus1, Knut Engedal2, Peter Høgh3,4, Vesna Jelic5,6, Morten Mørup7, Mala Naik8, Anne-Rita Oeksengaard5, Jon Snaedal9, Lars-Olof Wahlund5, Gunhild Waldemar1, Birgitte Bo Andersen1.   

Abstract

BACKGROUND: Quantitative EEG (qEEG) power could potentially be used as a diagnostic tool for Alzheimer's disease (AD) and may further our understanding of the pathophysiology. However, the early qEEG power changes of AD are not well understood.
OBJECTIVE: To investigate the early changes in qEEG power and the possible correlation with memory function and cerebrospinal fluid biomarkers. In addition, whether qEEG power could discriminate between AD, mild cognitive impairment (MCI), and older healthy controls (HC) at the individual level.
METHODS: Standard EEGs from 138 HC, 117 MCI, and 117 AD patients were included from six Nordic memory clinics. All EEGs were recorded consecutively before the diagnosis and were not used for the consensus diagnosis. Absolute and relative power was calculated for both eyes closed and open condition.
RESULTS: At group level using relative power, we found significant increases globally in the theta band and decreases in high frequency power in the temporal regions for eyes closed for AD and, to a lesser extent, for MCI compared to HC. Relative theta power was significantly correlated with multiple neuropsychological measures and had the largest correlation coefficient with total tau. At the individual level, the classification rate for AD and HC was 72.9% for relative power with eyes closed.
CONCLUSION: Our findings suggest that the increase in relative theta power may be the first change in patients with dementia due to AD. At the individual level, we found a moderate classification rate for AD and HC when using EEGs alone.

Entities:  

Keywords:  Alzheimer’s disease; EEG; dementia; diagnostic; mild cognitive impairment; power

Mesh:

Year:  2018        PMID: 29991135     DOI: 10.3233/JAD-180300

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  24 in total

1.  Neurophysiological Differences Between Women With Fibromyalgia and Healthy Controls During Dual Task: A Pilot Study.

Authors:  Santos Villafaina; Juan Pedro Fuentes-García; Ricardo Cano-Plasencia; Narcis Gusi
Journal:  Front Psychol       Date:  2020-11-04

2.  GSK-3β Disrupts Neuronal Oscillatory Function to Inhibit Learning and Memory in Male Rats.

Authors:  Abdalla M Albeely; Olivia O F Williams; Melissa L Perreault
Journal:  Cell Mol Neurobiol       Date:  2021-01-03       Impact factor: 5.046

3.  Cognitive Effects of Montelukast: A Pharmaco-EEG Study.

Authors:  Fabian Schwimmbeck; Wolfgang Staffen; Christopher Höhn; Fabio Rossini; Nora Renz; Markus Lobendanz; Peter Reichenpfader; Bernhard Iglseder; Ludwig Aigner; Eugen Trinka; Yvonne Höller
Journal:  Brain Sci       Date:  2021-04-27

Review 4.  Epileptic Mechanisms Shared by Alzheimer's Disease: Viewed via the Unique Lens of Genetic Epilepsy.

Authors:  Jing-Qiong Kang
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 5.  Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel.

Authors:  Claudio Babiloni; Xianghong Arakaki; Hamed Azami; Karim Bennys; Katarzyna Blinowska; Laura Bonanni; Ana Bujan; Maria C Carrillo; Andrzej Cichocki; Jaisalmer de Frutos-Lucas; Claudio Del Percio; Bruno Dubois; Rebecca Edelmayer; Gary Egan; Stephane Epelbaum; Javier Escudero; Alan Evans; Francesca Farina; Keith Fargo; Alberto Fernández; Raffaele Ferri; Giovanni Frisoni; Harald Hampel; Michael G Harrington; Vesna Jelic; Jaeseung Jeong; Yang Jiang; Maciej Kaminski; Voyko Kavcic; Kerry Kilborn; Sanjeev Kumar; Alice Lam; Lew Lim; Roberta Lizio; David Lopez; Susanna Lopez; Brendan Lucey; Fernando Maestú; William J McGeown; Ian McKeith; Davide Vito Moretti; Flavio Nobili; Giuseppe Noce; John Olichney; Marco Onofrj; Ricardo Osorio; Mario Parra-Rodriguez; Tarek Rajji; Petra Ritter; Andrea Soricelli; Fabrizio Stocchi; Ioannis Tarnanas; John Paul Taylor; Stefan Teipel; Federico Tucci; Mitchell Valdes-Sosa; Pedro Valdes-Sosa; Marco Weiergräber; Gorsev Yener; Bahar Guntekin
Journal:  Alzheimers Dement       Date:  2021-04-15       Impact factor: 16.655

6.  Fast Alpha Activity in EEG of Patients With Alzheimer's Disease Is Paralleled by Changes in Cognition and Cholinergic Markers During Encapsulated Cell Biodelivery of Nerve Growth Factor.

Authors:  Helga Eyjolfsdottir; Thomas Koenig; Azadeh Karami; Per Almqvist; Göran Lind; Bengt Linderoth; Lars Wahlberg; Åke Seiger; Taher Darreh-Shori; Maria Eriksdotter; Vesna Jelic
Journal:  Front Aging Neurosci       Date:  2022-04-25       Impact factor: 5.702

7.  Resting EEG, Hair Cortisol and Cognitive Performance in Healthy Older People with Different Perceived Socioeconomic Status.

Authors:  Carolina Villada; Mauricio González-López; Herlinda Aguilar-Zavala; Thalía Fernández
Journal:  Brain Sci       Date:  2020-09-15

8.  Changes in the left temporal microstate are a sign of cognitive decline in patients with Alzheimer's disease.

Authors:  Christian S Musaeus; Knut Engedal; Peter Høgh; Vesna Jelic; Arjun R Khanna; Troels Wesenberg Kjaer; Morten Mørup; Mala Naik; Anne-Rita Oeksengaard; Emiliano Santarnecchi; Jon Snaedal; Lars-Olof Wahlund; Gunhild Waldemar; Birgitte B Andersen
Journal:  Brain Behav       Date:  2020-04-27       Impact factor: 2.708

9.  Z-score neurofeedback, heart rate variability biofeedback, and brain coaching for older adults with memory concerns.

Authors:  Kyle D Meeuwsen; Kayleah M Groeneveld; Linda A Walker; Anna M Mennenga; Rachel K Tittle; Elyse K White
Journal:  Restor Neurol Neurosci       Date:  2021       Impact factor: 2.406

10.  N-Pep-12 supplementation after ischemic stroke positively impacts frequency domain QEEG.

Authors:  Livia Livint Popa; Mihaela Iancu; Gheorghe Livint; Maria Balea; Constantin Dina; Vitalie Vacaras; Cristian Vladescu; Laura Balanescu; Anca Dana Buzoianu; Stefan Strilciuc; Dafin Muresanu
Journal:  Neurol Sci       Date:  2021-06-25       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.